C12N 2760/20233
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2760/20233 (Use of viral protein as therapeutic agent other than vaccine) appears on 2 US grants and 11 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 11
- Assignees
- 11
- Inventors
- 26
- Latest grant
- 26 Oct 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 2 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for treatment of tumor by using recombinant oncolytic virus in combination with small-molecule anticancer drug22 Jan 2026US 2026/0021149 A1Joint Biosciences (Sh) Ltd.
- Combinations of checkpoint inhibitors and oncolytic virus for treating cancer15 May 2025US 2025/0152643 A1Regeneron Pharmaceuticals, Inc.
- Recombinant oncolytic virus and use thereof15 May 2025US 2025/0152644 A1Joint Biosciences (Sh) Ltd.
- Oncolytic virus and use thereof11 Jul 2024US 2024/0226209 A1Joint Biosciences (Sh) Ltd.
- Non-naturally occurring capsids for delivery of nucleic acids and/or proteins8 Dec 2022US 2022/0389062 A1Massachusetts Institute of Technology
Most cited
By later US patents